申请人:Otsuka Pharmaceutical Co., Ltd.
公开号:US05238938A1
公开(公告)日:1993-08-24
The novel indole derivatives and salts thereof represented by the general formula (1) ##STR1## possess, for example, an inhibitory effect against superoxide (O.sub.2.sup.-) released from the macrophage cells of guinea pig by stimulation and an anti-albuminuria activity against Masugi nephritis, and are useful in various clinical fields as an agent for preventing and treating diseases and cases associated with the above superoxide radical, for example, autoimmune diseases (e.g. rheumatism), arteriosclerosis, ischemic disease, ischemic encephalopathia, hepatic insufficiency and renal insufficiency, and also as an agent for preventing and treating nephritis.
通式(1)所表示的新型吲哚衍生物及其盐,例如对豚鼠巨噬细胞通过刺激释放的超氧化物(O.sub.2.sup.-)具有抑制作用,并对Masugi肾炎具有抗蛋白尿活性,在各种临床领域中作为预防和治疗与上述超氧自由基相关的疾病和病例的药物,例如自身免疫性疾病(如风湿病),动脉硬化,缺血性疾病,缺血性脑病,肝功能不全和肾功能不全,以及预防和治疗肾炎方面具有用途。